Which factor relates to receptor interaction differences among patients?

Which factor relates to receptor interaction differences among patients?

• A. Concentration of endogenous receptor ligand
• B. The patient’s blood type
• C. The shelf life of the drug
• D. The dose form

Answer: (A)

The factor at play is the amount of the body's own ligand that binds to the receptor. Receptor interactions depend on occupancy: the drug and endogenous ligands compete for the same binding sites. If a patient has high levels of the endogenous ligand, more receptors are already occupied, so the drug has fewer receptors to bind and its effect may be reduced. If endogenous ligand levels are low, more receptors are available for the drug, leading to a stronger or more rapid effect. That variability in endogenous ligand concentrations among individuals explains why receptor-mediated responses can differ from patient to patient. The other options don’t directly determine how the receptor is engaged. Blood type isn’t a predictor of receptor binding at the pharmacodynamic level; shelf life affects stability, not receptor affinity; and dose form influences delivery to the site of action but not the intrinsic interaction with the receptor itself.

The factor at play is the amount of the body's own ligand that binds to the receptor. Receptor interactions depend on occupancy: the drug and endogenous ligands compete for the same binding sites. If a patient has high levels of the endogenous ligand, more receptors are already occupied, so the drug has fewer receptors to bind and its effect may be reduced. If endogenous ligand levels are low, more receptors are available for the drug, leading to a stronger or more rapid effect. That variability in endogenous ligand concentrations among individuals explains why receptor-mediated responses can differ from patient to patient.

The other options don’t directly determine how the receptor is engaged. Blood type isn’t a predictor of receptor binding at the pharmacodynamic level; shelf life affects stability, not receptor affinity; and dose form influences delivery to the site of action but not the intrinsic interaction with the receptor itself.